Skip to content

uniQure QURE Royalty Financing Agreement Interest Expense

Royalty Financing Agreement Interest Expense at other companies

BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$13.29M-1.6%
BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$13.29M-1.6%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$20.86M+15.5%
Nektar Therapeutics logo
Nektar TherapeuticsNKTR
$7.94M+59.7%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$343.91M+3.7%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
$39.87M+66.0%

Segments

By segment

See full
Single Reportable$12.62M-5.2%

Other financials

Income statement

See full
Revenue$3.6M+127%
Gross profit$3.3M+144%
Operating income-$45.7M-16.2%
Net income-$53.5M-22.7%
EPS (diluted)-$0.85-3.7%

Balance sheet

See full
Cash & equivalents$140.0M-35.6%
Total debt$63.3M-4.3%
Total equity$149.3M+343%
Total assets$778.7M+28.6%

Cash flow

See full
Operating cash flow-$38.2M+13.3%
CapEx$140.0K+11.1%
Free cash flow-$38.4M+13.2%

Valuation

See full
Market cap$3.08B+78.4%

Profitability

See full
Gross margin90.6%-2.9pp
Operating margin-1,059.7%+380pp
Net margin-1,154.4%+89.3pp
FCF margin-953.7%+169pp

Returns & leverage

See full
Return on equity-228.2%-11.6pp
Debt / equity0.4×-1.5×
Current ratio10.4×-1.6×

Where this comes from

Reported directly by uniQure in its filing.

Tagged under the XBRL concept qure:RoyaltyFinancingAgreementInterestExpense.

The official record: uniQure’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about uniQure's royalty financing agreement interest expense.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is uniQure's royalty financing agreement interest expense?
uniQure (QURE) reported royalty financing agreement interest expense of $7.17M in Q1 2026.
How has uniQure's royalty financing agreement interest expense changed year-over-year?
uniQure's royalty financing agreement interest expense decreased by 14.2% year-over-year, from $8.36M to $7.17M.
What does royalty financing agreement interest expense mean?
This captures the interest expense associated with specialized financing arrangements where future royalty streams are pledged as collateral. It reflects the cost of capital for non-dilutive funding mechanisms common in biotechnology. Monitoring this helps assess the impact of royalty-based debt on long-term profitability.